Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011469
Filing Date
2025-08-14
Accepted
2025-08-14 07:00:01
Documents
71
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20250630x10q.htm   iXBRL 10-Q 1786329
2 EX-31.1 tmb-20250630xex31d1.htm EX-31.1 10843
3 EX-31.2 tmb-20250630xex31d2.htm EX-31.2 10735
4 EX-32.1 tmb-20250630xex32d1.htm EX-32.1 6912
5 EX-32.2 tmb-20250630xex32d2.htm EX-32.2 6649
  Complete submission text file 0001558370-25-011469.txt   8081394

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20250630.xsd EX-101.SCH 53150
7 EX-101.CAL tmb-20250630_cal.xml EX-101.CAL 48876
8 EX-101.DEF tmb-20250630_def.xml EX-101.DEF 238622
9 EX-101.LAB tmb-20250630_lab.xml EX-101.LAB 495052
10 EX-101.PRE tmb-20250630_pre.xml EX-101.PRE 385590
74 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250630x10q_htm.xml XML 1501722
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 251214210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)